Works matching DE "KINASE inhibitors"

Results: 3314
    1

    2024 Update of the Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis: Secondary publication.

    Published in:
    Modern Rheumatology, 2025, v. 35, n. 3, p. 387, doi. 10.1093/mr/roaf006
    By:
    • Harigai, Masayoshi;
    • Kaneko, Yuko;
    • Tanaka, Eiichi;
    • Hirata, Shintaro;
    • Kameda, Hideto;
    • Kaneko, Kayoko;
    • Kishimoto, Mitsumasa;
    • Kohno, Masataka;
    • Kojima, Masayo;
    • Kojima, Toshihisa;
    • Morinobu, Akio;
    • Nakajima, Ayako;
    • Sugihara, Takahiko;
    • Fusama, Mie;
    • Yajima, Nobuyuki;
    • Yanai, Ryo;
    • Kawahito, Yutaka
    Publication type:
    Article
    2
    3

    Several different cytogenetic clones arising during treatment of Philadelphia positive chronic myeloid leukemia with tyrosine kinase inhibitors lead to the progression into Philadelphia negative acute myeloid leukemia.

    Published in:
    Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2021, v. 78, n. 1, p. 114, doi. 10.2298/VSP180723010D
    By:
    • Denčić-Fekete, Marija;
    • Leković, Danijela;
    • Djordjević, Vesna;
    • Jovanović, Jelica;
    • Todorić-Živanović, Biljana;
    • Jaković, Ljubomir;
    • Bogdanović, Andrija
    Publication type:
    Article
    4

    Notch is a direct negative regulator of the DNA-damage response.

    Published in:
    Nature Structural & Molecular Biology, 2015, v. 22, n. 5, p. 417, doi. 10.1038/nsmb.3013
    By:
    • Vermezovic, Jelena;
    • Adamowicz, Marek;
    • Santarpia, Libero;
    • Rustighi, Alessandra;
    • Forcato, Mattia;
    • Lucano, Caterina;
    • Massimiliano, Lucia;
    • Costanzo, Vincenzo;
    • Bicciato, Silvio;
    • Del Sal, Giannino;
    • d'Adda di Fagagna, Fabrizio
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Cover Feature: Optimization of the Lead Compound NVP‐BHG712 as a Colorectal Cancer Inhibitor (Chem. Eur. J. 23/2023).

    Published in:
    Chemistry - A European Journal, 2023, v. 29, n. 23, p. 1, doi. 10.1002/chem.202300918
    By:
    • Tröster, Alix;
    • DiPrima, Michael;
    • Jores, Nathalie;
    • Kudlinzki, Denis;
    • Sreeramulu, Sridhar;
    • Gande, Santosh L.;
    • Linhard, Verena;
    • Ludig, Damian;
    • Schug, Alexander;
    • Saxena, Krishna;
    • Reinecke, Maria;
    • Heinzlmeir, Stephanie;
    • Leisegang, Matthias S.;
    • Wollenhaupt, Jan;
    • Lennartz, Frank;
    • Weiss, Manfred S.;
    • Kuster, Bernhard;
    • Tosato, Giovanna;
    • Schwalbe, Harald
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations.

    Published in:
    JNCI Cancer Spectrum, 2024, v. 8, n. 3, p. 1, doi. 10.1093/jncics/pkae030
    By:
    • Necchi, Andrea;
    • Ramlau, Rodryg;
    • González, Alejandro Falcón;
    • Chaudhry, Arvind;
    • Todenhöfer, Tilman;
    • Tahbaz, Rana;
    • Fontana, Elisa;
    • Giannatempo, Patrizia;
    • Deville, Jean-Laurent;
    • Pouessel, Damien;
    • Yoon, Shinkyo;
    • Powles, Thomas;
    • Bernat, Mathieu;
    • Häckl, Manuel;
    • Marszewska, Michalina;
    • McKernan, Phil;
    • Saulay, Mikael;
    • Scaleia, Federica;
    • Engelhardt, Marc;
    • Loriot, Yohann
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50